Standout Papers

Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, p... 2017 2026 2020 2023 356
  1. Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial (2017)
    Martin Alberer, Ulrike Gnad-Vogt et al. The Lancet

Citation Impact

33 by Nobel laureates 15 from Science/Nature 80 standout
Sub-graph 1 of 22

Citing Papers

Probiotic neoantigen delivery vectors for precision cancer immunotherapy
2024 StandoutNature
Polymeric Nanoparticles for Drug Delivery
2024 Standout
4 intermediate papers

Works of Linus Backert being referenced

Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
2017 Standout
HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL)
2014
and 2 more

Author Peers

Author Immunology Molecular Biology Oncology Infectious Diseases Last Decade Papers Cites
Linus Backert 449 632 223 288 18 1.0k
Cankon Germíyanoğlu 7 52 11 16 79 888
Seyed Yahya Nikouei 5 53
Navakanta Bhat 22 226
K Chandramohan 8 67 134 38 46 387
O. Obakponovwe 6 1 8 12 395

All Works

Loading papers...

Rankless by CCL
2026